Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.
BACKGROUND:The incidence of multiple sclerosis (MS) is rising in women. OBJECTIVE:To determine whether the use of combined oral contraceptives (COCs) are associated with MS risk and whether this varies by progestin content. METHODS:We conducted a nested case-control study of females ages 14-48 years...
Main Authors: | Kerstin Hellwig, Lie H Chen, Frank Z Stancyzk, Annette M Langer-Gould |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4780760?pdf=render |
Similar Items
-
Multiple sclerosis, rituximab, and COVID‐19
by: Annette Langer‐Gould, et al.
Published: (2021-04-01) -
How much radiologically isolated syndrome suggestive of multiple sclerosis is multiple sclerosis?
by: Marco Aurélio Lana-Peixoto
Published: (2012-01-01) -
Immunomodulation and postpartum relapses in patients with multiple sclerosis
by: Kerstin Hellwig, et al.
Published: (2009-01-01) -
PSYCHOEMOTIONAL REACTIONS AT THE STAGE OF CLINICALLY ISOLATED MULTIPLE SCLEROSIS SYNDROME
by: Olga D. Shulga
Published: (2019-12-01) -
Anxiety and depressive symptoms in clinically isolated syndrome and multiple sclerosis
by: Carolina Fiorin Anhoque, et al.
Published: (2011-12-01)